Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Multiple Functions of B Cells in Chronic HBV Infection
Ying Cai, Wenwei Yin
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MS
René Carvajal, David Guananga-Álvarez, Carmen Tur, et al.
Neurology (2025) Vol. 104, Iss. 3
Closed Access | Times Cited: 2
Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
Arshi Khanam, Joel V. Chua, Shyam Kottilil
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5497-5497
Open Access | Times Cited: 91
Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity
Peiyu Zheng, Yong‐Qing Dou, Qinying Wang
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 23
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma
Marco Y. W. Zaki, Ahmed M. Fathi, Samara Samir, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1255-1255
Open Access | Times Cited: 36
Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses
Ming‐Ling Chang, Yun‐Fan Liaw
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1552-1552
Open Access | Times Cited: 31
Participation of B cell in immunotherapy of cancer
Nikhil Chandnani, I.D. Gupta, Ayush Mandal, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155169-155169
Closed Access | Times Cited: 6
Elimination of the hepatitis B virus: A goal, a challenge
Robério Amorim de Almeida Pondé, Guilherme de Sousa Pondé Amorim
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2015-2034
Closed Access | Times Cited: 6
Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis
Fangming Yang, Heng Li, Yanmin Li, et al.
International Immunopharmacology (2021) Vol. 99, pp. 108051-108051
Closed Access | Times Cited: 40
Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
Hyo Jung Cho, Jae Youn Cheong
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8011-8011
Open Access | Times Cited: 31
A Comprehensive Review of Hepatitis B Vaccine Nonresponse and Associated Risk Factors
Albashir Tahir, Saadatu Haruna Shinkafi, Ahmed Subeh Alshrari, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 710-710
Open Access | Times Cited: 4
B cells in non-lymphoid tissues
Abrar Samiea, George Celis, Rashi Yadav, et al.
Nature reviews. Immunology (2025)
Closed Access
The role of immune regulation in HBV infection and hepatocellular carcinogenesis
Hailong Zheng, Bingchen Xu, Yiyu Fan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Functional Cure for Hepatitis B Virus: Challenges and Achievements
Oren Shechter, Daniel Sausen, Harel Dahari, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3633-3633
Open Access
Toll‐like receptor 7 agonist, GS‐986, is an immune‐stimulant inducing follicular helper T cells and expanding HBs antigen‐specific B cells in vitro
Taizo Mori, Sachiyo Yoshio, Shiori Yoshikawa, et al.
Liver International (2023) Vol. 43, Iss. 6, pp. 1213-1224
Closed Access | Times Cited: 6
Prospects for NK-based immunotherapy of chronic HBV infection
Xiaomeng Jin, Jiacheng Bi
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Interferon α facilitates anti-HBV cellular immune response in a B cell-dependent manner
Shihong Zhong, Qiong Li, Chunhua Wen, et al.
Antiviral Research (2022) Vol. 207, pp. 105420-105420
Closed Access | Times Cited: 8
A Rare AIOLOS N160S Variant Causing IEI in Human
Öner Özdemır, Ümmügülsüm Dikici, Murat Hakkı Yarar, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 2
Closed Access | Times Cited: 1
Comparison of B cells' immune response induced by PEDV virulent and attenuated strains
Yuan Chen, Zhao Xue, Yawen Feng, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
B cells enhance EphA2 chimeric antigen receptor T cells cytotoxicity against glioblastoma via improving persistence
Ying Zhang, Aiqin Gu, Zhijing An, et al.
Human Immunology (2024) Vol. 85, Iss. 6, pp. 111093-111093
Closed Access | Times Cited: 1
Enhanced Delivery of TLR7/8 Agonists by Metal–Organic Frameworks for Hepatitis B Virus Cure
Liyuan Wang, Guiqiang Zhang, Yang Sun, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 41, pp. 46176-46187
Closed Access | Times Cited: 7
The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming
Zhengmin Wang, Nan Liu, Yang Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection
Harry L.A. Janssen, Young‐Suk Lim, Hyung Joon Kim, et al.
JHEP Reports (2023) Vol. 6, Iss. 2, pp. 100975-100975
Open Access | Times Cited: 3
Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure
Andrew Vaillant
Viruses (2021) Vol. 13, Iss. 5, pp. 745-745
Open Access | Times Cited: 7
Sustained Liver HBsAg Loss and Clonal T- and B-Cell Expansion upon Therapeutic DNA Vaccination Require Low HBsAg Levels
Nádia Conceição‐Neto, Wim Pierson, Maurizio Vacca, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1825-1825
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top